Aldagen
Aldagen develops regenerative cell therapies for inherited metabolic diseases, leukemia, critical limb ischemia and ischemic heart failure.
Launch date
Employees
Market cap
-
Enterprise valuation
$74—110m (Dealroom.co estimates Apr 2008.)
Durham North Carolina (HQ)
Authorizing premium user...